HiFiBiO grabs $75m Series D
HiFiBiO Therapeutics, a multinational biotechnology company, has secured $75 million in Series D financing.
14 June 2021•1 min read
HiFiBiO Therapeutics, a multinational biotechnology company, has secured $75 million in Series D financing.